Virtu Financial’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,418
| Closed | -$8K | – | 2081 |
|
|
2023
Q2 | $8K | Buy |
+1,418
| New | +$8K | ﹤0.01% | 1375 |
|
|
2023
Q1 | – | Sell |
-2,264
| Closed | -$67K | – | 2283 |
|
|
2022
Q4 | $67K | Buy |
+2,264
| New | +$67K | 0.01% | 1031 |
|
|
2021
Q4 | – | Sell |
-747
| Closed | -$58K | – | 2289 |
|
|
2021
Q3 | $58K | Buy |
+747
| New | +$58K | 0.01% | 1249 |
|
|
2020
Q4 | – | Sell |
-3,059
| Closed | -$316K | – | 1885 |
|
|
2020
Q3 | $316K | Buy |
3,059
+1,126
| +58% | +$116K | 0.05% | 417 |
|
|
2020
Q2 | $76K | Buy |
+1,933
| New | +$76K | 0.01% | 941 |
|
|
2019
Q3 | – | Sell |
-167
| Closed | -$23K | – | 1914 |
|
|
2019
Q2 | $23K | Buy |
+167
| New | +$23K | ﹤0.01% | 1315 |
|
|
2019
Q1 | – | Sell |
-91
| Closed | -$11K | – | 1953 |
|
|
2018
Q4 | $11K | Sell |
91
-40
| -31% | -$4.84K | ﹤0.01% | 1425 |
|
|
2018
Q3 | $54K | Buy |
131
+38
| +41% | +$15.7K | ﹤0.01% | 1284 |
|
|
2018
Q2 | $50K | Sell |
93
-115
| -55% | -$61.8K | ﹤0.01% | 1748 |
|
|
2018
Q1 | $96K | Buy |
208
+153
| +278% | +$70.6K | 0.01% | 1588 |
|
|
2017
Q4 | $37K | Sell |
55
-63
| -53% | -$42.4K | ﹤0.01% | 2123 |
|
|
2017
Q3 | $75K | Buy |
+118
| New | +$75K | ﹤0.01% | 2144 |
|